Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Green_Cross_Biotech
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:CEO |
gptkb:Hoon_Kim
|
| gptkbp:certifications |
gptkb:FDA
gptkb:ISO_9001 gptkb:ISO_13485 KFDA |
| gptkbp:clinicalTrials |
Completed
Ongoing Planned |
| gptkbp:collaborations |
Academic institutions
Government agencies Research organizations |
| gptkbp:communityEngagement |
Sponsorships
Health education programs Volunteer_initiatives |
| gptkbp:employees |
Over 1,000
|
| gptkbp:expansion |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:founded |
1967
|
| gptkbp:headquarters |
gptkb:Seongnam,_South_Korea
|
| https://www.w3.org/2000/01/rdf-schema#label |
Green Cross Corporation
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:innovation |
Cell therapy
Gene therapy Biopharmaceuticals |
| gptkbp:investmentFocus |
Infrastructure
Technology R&D |
| gptkbp:market |
Global
Growing_in_Europe Strong_in_Asia Emerging_in_North_America |
| gptkbp:partnerships |
Various global pharmaceutical companies
|
| gptkbp:patentCitation |
Numerous
|
| gptkbp:products |
Vaccines
Diagnostics Blood products |
| gptkbp:researchFocus |
Cancer
Autoimmune diseases Infectious diseases |
| gptkbp:revenue |
Approximately $500 million
|
| gptkbp:socialResponsibility |
Environmental sustainability
Community support Health initiatives |
| gptkbp:subsidiary |
gptkb:Green_Cross_Health
gptkb:Green_Cross_Lab |
| gptkbp:sustainability |
Waste reduction
Resource efficiency Carbon neutrality |
| gptkbp:website |
www.greencross.com
|